JeannaMariePiperMD

Obstetrics & Gynecology • Germantown, MD

Maternal & Fetal Medicine/High Risk

Physician

Join to view full profile

Dr. Piper is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Piper's full profile

Already have an account?

Office
18034 Red Rocks Dr
Germantown, MD 20874
Phone+1 301-916-4455

Education & Training

Tulane University School of MedicineClass of 1986

Certifications & Licensure

TX State Medical License 1990 - 2026
GA State Medical License 1989 - 2025
LA State Medical License 1986 - 2025
MD State Medical License 2006 - 2025
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Maternal-Fetal Medicine

Publications & Presentations

PubMed

Acceptability of the Dapivirine Vaginal Ring and Daily Oral Pre-exposure Prophylaxis (PrEP) during Pregnancy in Malawi, South Africa, Uganda, and Zimbabwe.
Alinda M Young, Marie C D Stoner, Florence Mathebula, Rebone Mohuba, Alejandro Baez
AIDS and Behavior. 2024-11-01
Phase 1 randomized pharmacokinetic and safety study of a 90-day tenofovir vaginal ring in the United States.
Albert Y Liu, Holly Gundacker, Barbra Richardson, Beatrice A Chen, Craig Hoesley
Journal of the International AIDS Society. 2024-03-01
3 citations
Acceptability of the Dapivirine Vaginal Ring and Oral Truvada Among African Users in Late-Stage of Pregnancy.
Elizabeth T Montgomery, Imogen Hawley, Lee Fairlie, Katie Bunge, Florence Mathebula
AIDS and Behavior. 2024-03-01

Journal Articles

Phase 1 Safety and Pharmacokinetics Study of MK-2048/Vicriviroc (MK-4176)/MK-2048A Intravaginal Rings
Craig J Hoesley, Beatrice A Chen, Jeanna Piper, Clinical Infectious Diseases
Phase 1 Pharmacokinetic Trial of 2 Intravaginal Rings Containing Different Dose Strengths of Vicriviroc (MK-4176) and MK-2048
Jeanna Piper, MD, Clinical Infectious Diseases

Grant Support

Clinical Aspects Of Virus-Harboring Trichomonas VaginalisNational Institute Of Allergy And Infectious Diseases1999–2002